Covid-19 Interface with Drug Misuse and Substance Use Disorders

Overview

Journal Neuropharmacology

Specialties Neurology
Pharmacology

Date 2021 Aug 29

PMID 34454912

Citations 13

Authors

I E Cisneros

K A Cunningham

Affiliations

Soon will be listed here.

Abstract

The coronavirus disease 2019 (Covid-19) pandemic intensified the already catastrophic drug overdose and substance use disorder (SUD) epidemic, signaling a syndemic as social isolation, economic and mental health distress, and disrupted treatment services disproportionally impacted this vulnerable population. Along with these social and societal factors, biological factors triggered by intense stress intertwined with incumbent overactivity of the immune system and the resulting inflammatory outcomes may impact the functional status of the central nervous system (CNS). We review the literature concerning SARS-CoV2 infiltration and infection in the CNS and the prospects of synergy between stress, inflammation, and kynurenine pathway function during illness and recovery from Covid-19. Taken together, inflammation and neuroimmune signaling, a consequence of Covid-19 infection, may dysregulate critical pathways and underlie maladaptive changes in the CNS, to exacerbate the development of neuropsychiatric symptoms and in the vulnerability to develop SUD. This article is part of the special Issue on 'Vulnerabilities to Substance Abuse'.

Citing Articles

Transcriptomic Profile of the Male Rat Hypothalamus and Nucleus Accumbens After Paroxetine Treatment and Withdrawal: Possible Causes of Sexual Dysfunction.

Giatti S, Cioffi L, Diviccaro S, Chrostek G, Piazza R, Melcangi R Mol Neurobiol. 2024; 62(4):4935-4951.

PMID: 39495228 DOI: 10.1007/s12035-024-04592-9.

Differences in the Rates of Diagnoses of Mental and Behavioral Disorders Due to Psychoactive Substance Use by Sex and Age during Pre-Pandemic and COVID-19 Pandemic Periods in Kazakhstan.

Akkuzinova K, Inoue K, Toleuov E, Moldagaliyev T, Seksenbayev N, Jamedinova U Healthcare (Basel). 2024; 12(20).

PMID: 39451427 PMC: 11506856. DOI: 10.3390/healthcare12202012.

Walk-in mental health: Bridging barriers in a pandemic.

Wellspring I, Ganesh K, Kreklewetz K PLoS One. 2024; 19(5):e0302543.

PMID: 38820293 PMC: 11142450. DOI: 10.1371/journal.pone.0302543.

Conceptualizing COVID-19 syndemics: A scoping review.

Bulled N, Singer M J Multimorb Comorb. 2024; 14:26335565241249835.

PMID: 38682155 PMC: 11055430. DOI: 10.1177/26335565241249835.

Assessing the risk of COVID-19 reinfection and severe outcomes among individuals with substance use disorders: a retrospective study using real-world electronic health records.

Tuan W, Kindt H, Lennon R BMJ Open. 2023; 13(12):e074993.

PMID: 38072495 PMC: 10729165. DOI: 10.1136/bmjopen-2023-074993.

References

Kowitt S, Ross J, Jarman K, Kistler C, Lazard A, Ranney L . Tobacco Quit Intentions and Behaviors among Cigar Smokers in the United States in Response to COVID-19. Int J Environ Res Public Health. 2020; 17(15). PMC: 7432467. DOI: 10.3390/ijerph17155368. View

Fraser D, Slessarev M, Martin C, Daley M, Patel M, Miller M . Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers. Crit Care Explor. 2020; 2(10):e0272. PMC: 7587450. DOI: 10.1097/CCE.0000000000000272. View

Koob G, Kreek M . Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry. 2007; 164(8):1149-59. PMC: 2837343. DOI: 10.1176/appi.ajp.2007.05030503. View

Steiner J, Carneiro A, Blakely R . Going with the flow: trafficking-dependent and -independent regulation of serotonin transport. Traffic. 2008; 9(9):1393-402. PMC: 2773847. DOI: 10.1111/j.1600-0854.2008.00757.x. View

Schulz S, Landi A, Garg R, Wilson J, van Drunen Littel-van den Hurk S . Indolamine 2,3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients. Clin Exp Immunol. 2015; 180(3):484-98. PMC: 4449777. DOI: 10.1111/cei.12586. View

Kohno M, Link J, Dennis L, McCready H, Huckans M, Hoffman W . Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies. Pharmacol Biochem Behav. 2019; 179:34-42. PMC: 6637953. DOI: 10.1016/j.pbb.2019.01.007. View

Ramani A, Muller L, Ostermann P, Gabriel E, Abida-Islam P, Muller-Schiffmann A . SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J. 2020; 39(20):e106230. PMC: 7560208. DOI: 10.15252/embj.2020106230. View

Blednov Y, Benavidez J, Black M, Mayfield J, Harris R . Role of interleukin-1 receptor signaling in the behavioral effects of ethanol and benzodiazepines. Neuropharmacology. 2015; 95:309-20. PMC: 4465986. DOI: 10.1016/j.neuropharm.2015.03.015. View

Puelles V, Lutgehetmann M, Lindenmeyer M, Sperhake J, Wong M, Allweiss L . Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J Med. 2020; 383(6):590-592. PMC: 7240771. DOI: 10.1056/NEJMc2011400. View

10.

Kovalevich J, Yen W, Ozdemir A, Langford D . Cocaine induces nuclear export and degradation of neuronal retinoid X receptor-γ via a TNF-α/JNK- mediated mechanism. J Neuroimmune Pharmacol. 2015; 10(1):55-73. PMC: 4336643. DOI: 10.1007/s11481-014-9573-x. View

11.

Nylen K, Ost M, Csajbok L, Nilsson I, Blennow K, Nellgard B . Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome. J Neurol Sci. 2005; 240(1-2):85-91. DOI: 10.1016/j.jns.2005.09.007. View

12.

Boulanger L . Immune proteins in brain development and synaptic plasticity. Neuron. 2009; 64(1):93-109. DOI: 10.1016/j.neuron.2009.09.001. View

13.

Watanabe M, Nakamura Y, Michalak Z, Isobe N, Barro C, Leppert D . Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD. Neurology. 2019; 93(13):e1299-e1311. DOI: 10.1212/WNL.0000000000008160. View

14.

Mahajan S, Aalinkeel R, Sykes D, Reynolds J, Bindukumar B, Adal A . Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse. Brain Res. 2008; 1203:133-48. PMC: 2826119. DOI: 10.1016/j.brainres.2008.01.093. View

15.

Cantuti-Castelvetri L, Ojha R, Pedro L, Djannatian M, Franz J, Kuivanen S . Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020; 370(6518):856-860. PMC: 7857391. DOI: 10.1126/science.abd2985. View

16.

Reynolds J, Mahajan S . SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation. J Neuroimmune Pharmacol. 2021; 16(1):4-6. PMC: 7786155. DOI: 10.1007/s11481-020-09975-y. View

17.

Lacagnina M, Rivera P, Bilbo S . Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse. Neuropsychopharmacology. 2016; 42(1):156-177. PMC: 5143481. DOI: 10.1038/npp.2016.121. View

18.

Yang T, Zang S, Wang Y, Zhu Y, Jiang L, Chen X . Methamphetamine induced neuroinflammation in mouse brain and microglial cell line BV2: Roles of the TLR4/TRIF/Peli1 signaling axis. Toxicol Lett. 2020; 333:150-158. DOI: 10.1016/j.toxlet.2020.07.028. View

19.

He J, Crews F . Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp Neurol. 2008; 210(2):349-58. PMC: 2346541. DOI: 10.1016/j.expneurol.2007.11.017. View

20.

Cunningham K, Anastasio N . Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction. Neuropharmacology. 2013; 76 Pt B:460-78. PMC: 4090081. DOI: 10.1016/j.neuropharm.2013.06.030. View